Enterprise Value
37.33M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
42.47%
Institutional Own.
0.40%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EVX-01 Details Solid tumor/s, Cancer, Melanoma | Phase 2b Interim update | |
EVX-02 Details Melanoma | Phase 1/2 Update |